Maternal malaria parasitemia.
malaria, parasitemia
MALARIA, REGRESSION, PARASITEMIA
The overall proportion (Proportion of malaria parasitemia positive samples, using the locally weighted scatterplot smoothing technique with bandwidth (0.2). AZI-SP = intervention group with monthly sulfadoxine-pyrimethamine (SP) and two doses of azithromycin.Proportion of maternal malaria parasitemia by intervention group during the whole pregnancy and the second and third trimesters of pregnancy separatelyAZI = azithromycin; OR = odds ratio; SP = sulfadoxine-pyrimethamine.Unadjusted proportions.Estimated with mixed-effects logistic regression, adjusted for polymerase chain reaction test result at enrollment, number of previous pregnancies, and duration of pregnancy at the time of malaria test.Second trimester from 14 weeks + 0 days of gestation to 26 weeks + 6 days of gestation; third trimester from 27 weeks + 0 days of gestation to the end of pregnancy.There was no statistically significant interaction on the proportion of malaria parasitemia between the intervention group and number of previous pregnancies (Proportion of maternal malaria parasitemia by intervention group throughout pregnancy, stratified by number of previous pregnancies, HIV status, and use of bed net during previous night before enrollmentAZI = azithromycin; OR = odds ratio; SP = sulfadoxine-pyrimethamine.Unadjusted proportions.Estimated with mixed-effects logistic regression, adjusted for malaria parasitemia status (polymerase chain reaction) at enrollment, number of previous pregnancies (except when stratified by number of previous pregnancies), and duration of pregnancy at the time of malaria test.